S

Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281

Watchlist Manager
Shandong Keyuan Pharmaceutical Co Ltd
SZSE:301281
Watchlist
Price: 31.12 CNY 1.3% Market Closed
Market Cap: 2.2B CNY

Operating Margin
Shandong Keyuan Pharmaceutical Co Ltd

9.1%
Current
11%
Average
5.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
9.1%
=
Operating Profit
39.7m
/
Revenue
435.5m

Operating Margin Across Competitors

No Stocks Found

Shandong Keyuan Pharmaceutical Co Ltd
Glance View

Market Cap
2.2B CNY
Industry
Pharmaceuticals

Shandong Keyuan Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical raw materials, and chemical preparation. The company is headquartered in Jinan, Shandong. The company went IPO on 2023-04-04. The firm's main products include gliclazide, metformin hydrochloride, ropivacaine hydrochloride and others. The firm's products are used in hypoglycemic, anesthetic, cardiovascular and psychiatric diseases. The firm conducts its operations mainly in the domestic market.

Shandong Keyuan Pharmaceutical Co Ltd Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
9.1%
=
Operating Profit
39.7m
/
Revenue
435.5m
What is the Operating Margin of Shandong Keyuan Pharmaceutical Co Ltd?

Based on Shandong Keyuan Pharmaceutical Co Ltd's most recent financial statements, the company has Operating Margin of 9.1%.

Back to Top